Sat.Jul 20, 2024 - Fri.Jul 26, 2024

article thumbnail

New study shows at-home colon cancer screening test reduces risk of colorectal cancer death, as effective as screening colonoscopy

Science Daily: Pharmacology News

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study.

359
359
article thumbnail

Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic

Drugs.com

TUESDAY, July 23, 2024 -- The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds. New prescriptions for these drugs have d.

Drugs 299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ionis plots next steps for Angelman drug Biogen passed on

BioPharma Drive: Drug Pricing

The company plans to start a late-stage study next year, after a smaller trial found its drug offered “robust and consistent” benefits on communication, cognition and motor function.

Drugs 288
article thumbnail

Drug Discovery Industry Roundup with Barry Bunin — July, 22 2024

Collaborative Drug

How A.I. Is Revolutionizing Drug Development. Holy Grail for Weight-Loss Drugs Is Sleep Apnea? DNA Discovery that Could Help Find Pancreatic Cancer Cure.

DNA 263
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Scientists assess how large dinosaurs could really get

Science Daily: Pharmacology News

A study looks at the maximum possible sizes of dinosaurs, using the carnivore, Tyrannosaurus rex, as an example. Using computer modelling, experts produced estimates that T. Rex might have been 70% heavier than what the fossil evidence suggests.

359
359

More Trending

article thumbnail

Sanofi’s immunology bet starts to pay off

BioPharma Drive: Drug Pricing

Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.

Therapies 277
article thumbnail

CDD Vault Update (July 2024)

Collaborative Drug

Inventory Search Interface: The new CDD Vault Inventory tab can be enabled by the CDD Support Team. If you wish to enable this tab in your vault please have your vault administrator contact support@collaborativedrug.com.

259
259
article thumbnail

New drug shows promise in clearing HIV from brain

Science Daily: Pharmacology News

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Virus 356
article thumbnail

Certain Abbott Blood Sugar Monitors May Give Incorrect Readings

Drugs.com

FRIDAY, July 26, 2024 -- Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3.

290
290
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Autobahn raises $100M on investor interest in neuropsych drugs

BioPharma Drive: Drug Pricing

Autobahn’s lead candidate is designed to stimulate thyroid hormone receptors as a way to complement existing antidepressants.

Drugs 273
article thumbnail

Cannabis and Cannabinoid Signaling: Research Gaps and Opportunities [Commentary]

ASPET

Cannabis and its products have been used for centuries for both medicinal and recreational purposes. The recent widespread legalization of cannabis has vastly expanded its use in the United States across all demographics except for adolescents. Meanwhile decades of research have advanced our knowledge of cannabis pharmacology and particularly of the endocannabinoid system with which the components of cannabis interact.

Research 189
article thumbnail

Researchers develop state-of-the-art device to make artificial intelligence more energy efficient

Science Daily: Pharmacology News

Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.

Research 351
article thumbnail

Bird Flu Is Now Transmitting Mammal-to-Mammal: Study

Drugs.com

THURSDAY, July 25, 2024 -- The bird flu is now jumping between species of mammals, a step that draws the virus closer to hopping into human beings, a new study warns.Researchers have tracked transmission of avian influenza between dairy cows in.

Virus 290
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Breakthroughs in immunotherapy: glycoproteins as predictive biomarkers for therapeutic response

BioPharma Drive: Drug Pricing

Serum-based glycoproteins demonstrate success in predicting immune checkpoint inhibitor therapy outcomes.

Therapies 273
article thumbnail

Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor

Covalent Modifiers

Darragh P O’Brien, Hannah BL Jones, Yuqi Shi, Franziska Guenther, Iolanda Vendrell, Rosa Viner, Paul E Brennan, Emma Mead, Tryfon Zarganes-Tzitzikas, John B Davis, Adán Pinto-Fernández, Katherine S England, Emma J Murphy, Andrew P Turnbull, Benedikt M Kessler bioRxiv 2024.07.20.604388; doi: [link] Inhibition of the mitochondrial deubiquitinating enzyme USP30 is neuroprotective and presents therapeutic opportunities for the treatment of idiopathic Parkinson’s Disease and mitophagy-related disorde

article thumbnail

Breakthrough in skeletal muscle regeneration

Science Daily: Pharmacology News

In a finding that opens the door to the development of targeted therapies for various muscle disorders, newly published research identifies key mechanisms of skeletal muscle regeneration and growth of muscles following resistance exercise.

Therapies 339
article thumbnail

'Two-Target' Antibiotics Could Make Bacterial Resistance Much Tougher

Drugs.com

THURSDAY, July 25, 2025 -- Synthetic antibiotics that attack bacteria in two directions at once could be the solution for combatting antimicrobial-resistant bugs, a new study claims.These dual-action antibiotics, called macrolones, disrupt.

290
290
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Private biotech M&A surges amid difficult IPO market

BioPharma Drive: Drug Pricing

Private biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not yet public, drug startups.

Marketing 249
article thumbnail

Recap of 2024 CDD Korean Life Science Community Meeting

Collaborative Drug

Celebrating 20 Years of Pioneering Drug Discovery and Collaboration: CDD User Group Meeting

Science 147
article thumbnail

Are AI-chatbots suitable for hospitals?

Science Daily: Pharmacology News

Large language models may pass medical exams with flying colors but using them for diagnoses would currently be grossly negligent. Medical chatbots make hasty diagnoses, do not adhere to guidelines, and would put patients' lives at risk. A team has systematically investigated whether this form of artificial intelligence (AI) would be suitable for everyday clinical practice.

Hospitals 338
article thumbnail

Big Drop in U.S. Kids, Teens Misusing Prescription Meds

Drugs.com

WEDNESDAY, July 24, 2024 -- Misuse of illicit prescription drugs is falling dramatically among U.S. high school students, a new study says.The percentage of seniors who say they’ve misused prescription drugs in the past year has dropped to 2% in 2.

Drugs 289
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Startup led by former J&J executives raises $165M for cancer, immune disease drugs

BioPharma Drive: Drug Pricing

Peter Lebowitz, who for years led J&J’s oncology R&D, is the CEO of the startup, called Third Arc Bio and launched by Omega Funds in 2022.

Disease 207
article thumbnail

Raising Welfare for Lab Rodents

Codon

Xander Balwit offers concrete proposals for raising the welfare of animals used in biomedical research for our final article in Issue 03. We’ll be on a brief hiatus for the next few weeks as we prepare for the next Issue! If you’d like to write for us, send a pitch to editors@asimov.com. A hairless and obese rat grimaced at me from behind the glass—its taxidermied gaze fixed on something across the room.

Research 123
article thumbnail

Trees reveal climate surprise -- bark removes methane from the atmosphere

Science Daily: Pharmacology News

Tree bark surfaces play an important role in removing methane gas from the atmosphere.

337
337
article thumbnail

Daily Supplements May Slow 'Dry' Form of Macular Degeneration

Drugs.com

MONDAY, July 22, 2024 -- Daily supplements can slow loss of vision related to late-stage “dry” age-related macular degeneration (AMD), a new study finds.The rate of dry AMD progression into a key eye region slowed by about 55% over an average three.

290
290
article thumbnail

J&J seeks expanded approval for antidepressant Spravato

BioPharma Drive: Drug Pricing

The company is seeking a monotherapy approval for Spravato, sales of which have climbed in recent quarters.

204
204